New life could be coming to one of Louisville's most iconic buildings, sources tell LBF. Here's what we know.

Confidence in yourself creates the capacity to lift others. Fear that someone else’s success diminishes your own keeps ...

Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana ...

Louisville Business First reports that local developer is in the planning stages of converting the 27-story building.

Wondering if Humana is quietly turning into a value opportunity after a rough stretch, or if the stock is cheap for a reason?

Humana (HUM) has been upgraded to Buy at Jefferies, driven by a significantly improved earnings outlook. Read more here.

Humana Inc. is working with billionaire Mark Cuban on a potential pharmacy partnership, Cuban and Humana’s chief executive ...

Humana has been upgraded by Jefferies based on its diversification strategy for its Medicare Advantage offerings. The upgrade ...

Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $230.0 and $280.0 for Humana, spanning the last three months.

The acquisition strengthens Humana's offering in preventive care for children and young in Norway, particularly within family-based care, family support services and additional supportive measures. Fa ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...